Zobrazeno 1 - 10
of 220
pro vyhledávání: '"Anaplastic Lymphoma Kinase Positive"'
Publikováno v:
Journal of Applied Hematology, Vol 14, Iss 3, Pp 252-254 (2023)
Anaplastic lymphoma kinase positive (ALK+ve) large B-cell lymphoma (LBCL) is a rare, aggressive subtype of diffuse LBCL with unique morphological characteristics and unusual immunophenotypic features that have substantial overlap with other hematolog
Externí odkaz:
https://doaj.org/article/4b28a42b5cef4f26aa3f3e0658012d2f
Autor:
Herbert H. Loong, Carlos K. H. Wong, Linda K. S. Leung, Catherine P. K. Chan, Andrea Chang, Zheng-Yi Zhou, Jipan Xie, Meaghan Gibbs
Publikováno v:
Cost Effectiveness and Resource Allocation, Vol 18, Iss 1, Pp 1-9 (2020)
Abstract Introduction Lower-dose ceritinib (450 mg) once-daily with food was approved in 2018 in Hong Kong (HK) for first-line treatment of patients with anaplastic lymphoma kinase-positive (ALK +) advanced non-small cell lung cancer (NSCLC). This st
Externí odkaz:
https://doaj.org/article/436f8f37a082436bb28442a062ac874c
Publikováno v:
Indian Journal of Pathology and Microbiology, Vol 63, Iss 4, Pp 615-617 (2020)
ALK+ large B cell lymphoma (LBCL) is a very rare aggressive neoplasm. It accounts for less than 1% of diffuse large B cell lymphoma (DLBCL). This is a case report of ALK+ DLBCL in a 34-year-old woman with an ileocaecal mesenteric mass. Microscopicall
Externí odkaz:
https://doaj.org/article/f9896a6bd40842eab96eb29dcfb63e28
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Publikováno v:
Journal of Clinical and Scientific Research, Vol 8, Iss 2, Pp 95-97 (2019)
Anaplastic large cell lymphoma (ALCL) is a rare disease accounting for 10%–15% of all non-Hodgkin's lymphomas in children. It is distinguished from other lymphomas by their anaplastic cytology and constant membrane expression of the CD30 antigen. W
Externí odkaz:
https://doaj.org/article/386b831968f14800b0955f09e951a5a9
Autor:
Shuku Sato, Yotaro Tamai
Publikováno v:
Clinical Case Reports, Vol 8, Iss 10, Pp 2067-2068 (2020)
Abstract Anaplastic large cell lymphoma has a characteristic sinusoidal growth pattern that presents as pulmonary lymphangitic involvement causing respiratory distress. Recognition and prompt treatment of this entity can result in dramatic response t
Externí odkaz:
https://doaj.org/article/0238aebf42f14c8cbc44db6ac43c5cc5
Autor:
Shuang Huang, Ling Jin, Yonghong Zhang, Dong Chen, Meng Zhang, Jing Yang, Yi Liu, Yan-long Duan, Chunju Zhou, Chao Gao, Nan Zhang, Qin-Long Zheng, Zifen Gao, Mei Jin, Guang-Hua Zhu
Publikováno v:
World Journal of Clinical Cases
BACKGROUND Anaplastic lymphoma kinase-positive (ALK+) large B-cell lymphoma (LBCL) is a rare type of lymphoma with high invasiveness and rapid progression. It occurs in all age groups, but is extremely rare in children. The lesions mainly involve the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::30915157670fc9896f8feee09e189f31
http://europepmc.org/articles/PMC8173411
http://europepmc.org/articles/PMC8173411
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Rabab Gaafar, Abdul Rahman Jazieh, Hatem El Kadi, Hassan Errihani, Mohamed Magdy Abdallah, Fouad Al Dayel, Hassan Jaafar, Abeer A. Bahnassy, Ghazi Zaatari
Publikováno v:
JCO Global Oncology
PURPOSE Anaplastic lymphoma kinase ( ALK) gene alterations are potent oncogenic drivers in non–small-cell lung cancer (NSCLC). Tyrosine kinase inhibitors targeting the ALK pathway are effective in treating ALK-positive NSCLC. Around 5% of Asian and
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::69b3a3023996dad2efc80a543ce556dc
https://doi.org/10.1200/go.21.00067
https://doi.org/10.1200/go.21.00067
Publikováno v:
Korean Journal of Otorhinolaryngology-Head and Neck Surgery. 64:760-765
Anaplastic lymphoma kinase positive large B-cell lymphoma (ALK+LBCL) is a rare subtype of B-cell lymphoma with aggressive features and a poor prognosis. The rarity of this disease and similarity of microscopic features with undifferentiated epithelia
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::cc44375829d14fd6c2190e7e53f04641
https://doi.org/10.3342/kjorl-hns.2020.00703
https://doi.org/10.3342/kjorl-hns.2020.00703